Sort
39,280 grants matching “leukemia”
Molecular elucidation of the CBM complex in NF-kappaB activation by antigen recep
$380,250Hao Wu · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · AI
C21, a Transcriptional Regulator in Hematopoiesis
$380,250New York University School Of Medicine · R01 · FY2003 · HL
Diet and Alcohol Induced Epigenetic Changes in Oral Cavity Carcinogenesis Model
$380,250Lorraine J Gudas · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · AA
Structural Biology of AML (CBFA2) and AML1-ETO
$380,244John Hackett Bushweller · University Of Virginia · R01 · FY2010 · CA
Leaders of Scientific Research Programs
$380,239Peter A Jones · University Of Southern California · P30 · FY2014 · CA
Implications of Metabolic Regulation of BCL-2 Dependence for Myeloma Therapy
$380,239Malathy (mala) Shanmugam · Emory University · R01 · FY2021 · CA
ALL therapy and developing brains: MRI measures, genetic factors and cognition
$380,224Wilburn E. Reddick · St. Jude Children'S Research Hospital · R01 · FY2012 · CA
ALL therapy and developing brains: MRI measures, genetic factors and cognition
$380,224Wilburn E. Reddick · St. Jude Children'S Research Hospital · R01 · FY2011 · CA
ALL therapy and developing brains: MRI measures, genetic factors and cognition
$380,224Wilburn E. Reddick · St. Jude Children'S Research Hospital · R01 · FY2015 · CA
Biochemistry of Leukemia Virus Core Binding Factor
$380,174Nancy Asmussen Speck · University Of Pennsylvania · R01 · FY2013 · HL
Molecular analysis of ASH1L
$380,148Tatiana G Kutateladze · University Of Colorado Denver · R01 · FY2020 · CA
Molecular analysis of ASH1L
$380,148Tatiana G Kutateladze · University Of Colorado Denver · R01 · FY2025 · CA
TARGETING ANTIGEN-INDUCED ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEM
$380,146Chih-Chi Andrew Hu · Wistar Institute · R01 · FY2017 · CA
TARGETING ANTIGEN-INDUCED ER STRESS RESPONSE IN B-CELL CHRONIC LYMPHOCYTIC LEUKEM
$380,146Chih-Chi Andrew Hu · Wistar Institute · R01 · FY2016 · CA
Mechanism and Regulation of Human Nonhomologous DNA End Joining
$380,118Michael R Lieber · University Of Southern California · R01 · FY2019 · CA
Assessment of Clinical Retinoid Activity in Leukemia
$380,112Robert E Gallagher · Montefiore Medical Center (Bronx, Ny) · R01 · FY2008 · CA
Cancer and Leukemia Group B - The Ohio State University
$380,084Ohio State University · U10 · FY2005 · CA
Targeting DNA repair to eradicate TKi-refractory/resistant CML and Ph+ALL
$380,072Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2020 · CA
RETARGETING AGENTS TO TREAT AML
$380,068John F Dipersio · Washington University · R01 · FY2015 · CA
RETARGETING AGENTS TO TREAT AML
$380,068John F Dipersio · Washington University · R01 · FY2016 · CA
RETARGETING AGENTS TO TREAT AML
$380,068John F Dipersio · Washington University · R01 · FY2017 · CA
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen
$380,060Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
RARE CANCER CELL DETECTION METHOD
$380,049One Cell Systems, Inc · R44 · FY2002 · CA
Molecular Mechanisms of Adverse Metabolic Events by Asparaginase.
$380,041Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2015 · HD
Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment
$380,033Steven David Mittelman · University Of California Los Angeles · R01 · FY2017 · CA